+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia-Pacific Respiratory Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4591927
  • Report
  • June 2020
  • Region: Asia Pacific
  • 100 pages
  • Mordor Intelligence
UP TO OFF
until Dec 31st 2020
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3M Company
  • Dragerwerk AG
  • GE Healthcare
  • Koninklijke Philips NV
  • Smiths Medical
  • Teleflex Incorporated
  • MORE
The Asia-Pacific Respiratory Devices Market is expected to register a CAGR of 5.1% during the forecast period. The major factors driving the growth of the market in the Asia region is due to the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), TB, Asthma, and Sleep Apnea, technological advancements, increasing applications in-home care setting and increasing geriatric population.

As per economic and social commission for Asia and the Pacific (ESCAP), reports that the geriatric population in Asia-Pacific was around 548 million in 2019, accounting for more than half of the world’s total elderly population. It is estimated that, by 2050, Asia-Pacific may account for almost two-thirds of the world’s geriatric population. Hence, owing to the fact that asthma is a widely prevalent disease found in people over 65 years of age, the growing geriatric population is expected to drive market growth over the forecast period.

Furthermore, the technological advances, increasing portability, and ease of operation of devices along with that awareness programs in Asia such as the "Healthy Lung Programme" which is expected to show significant growth over the forecast period.

Key Market Trends

Therapeutic Devices Segment is Expected to Hold Significant Market Share During the forecast period in the Asia-Pacific Respiratory Devices Market

The therapeutic devices segment is expected to grow with the highest market share due to the growing geriatric population and rising incidence of chronic diseases such as chronic obstructive pulmonary disease (COPD) and Asthma. The respiratory therapeutic devices market is further divided into ventilators, nebulizers, inhalers, positive airway pressure devices, humidifiers, oxygen concentrators, reusable resuscitators, and other devices.

As per the Australian government, estimates that 1 in 20 Australians aged 45 and over have a chronic obstructive pulmonary disease (COPD). It’s the 5th leading cause of death in Australia. Furthermore, about 20% of people with chronic obstructive pulmonary disease (COPD) also have asthma, which is described as asthma-COPD overlap (also called asthma-COPD overlap syndrome, or ACOS) as per Lung Foundation Australia 2018 factsheet. Thus, owing to the above factors the segment is expected to show a healthy growth rate over the forecast period.

Competitive Landscape

The Asia-Pacific Respiratory Devices Market is consolidated competitive. The companies are implementing certain strategic initiatives, such as a merger, new product launch, acquisition, and partnerships that help them in strengthening their market position. Some of the companies which are currently dominating the market are GE Healthcare, Fisher & Paykel Healthcare Ltd, Koninklijke Philips NV, Smiths Medical, Dragerwerk AG, Teleflex Incorporated, 3M Company and DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare).

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M Company
  • Dragerwerk AG
  • GE Healthcare
  • Koninklijke Philips NV
  • Smiths Medical
  • Teleflex Incorporated
  • MORE
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as Chronic Obstructive Pulmonary Disease Patients (COPD), TB, Asthma, and Sleep Apnea
4.2.2 Technological Advancements and Increasing Applications in Homecare Setting
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices
5.1.1.1 Spirometers
5.1.1.2 Sleep Test Devices
5.1.1.3 Peak Flow Meters
5.1.1.4 Pulse Oximeters
5.1.1.5 Capnographs
5.1.1.6 Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices
5.1.2.1 CPAP Devices
5.1.2.2 BiPAP Devices
5.1.2.3 Humidifiers
5.1.2.4 Nebulizers
5.1.2.5 Oxygen Concentrators
5.1.2.6 Ventilators
5.1.2.7 Inhalers
5.1.2.8 Other Therapeutic Devices
5.1.3 By Disposables
5.1.3.1 Masks
5.1.3.2 Breathing Circuits
5.1.3.3 Other Disposables
5.2 Geography
5.2.1 Asia-Pacific
5.2.1.1 China
5.2.1.2 Japan
5.2.1.3 India
5.2.1.4 Australia
5.2.1.5 South Korea
5.2.1.6 Rest of Asia-Pacific

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GE Healthcare
6.1.2 Fisher & Paykel Healthcare Ltd
6.1.3 Koninklijke Philips NV
6.1.4 Smiths Medical
6.1.5 Dragerwerk AG
6.1.6 Teleflex Incorporated
6.1.7 3M Company
6.1.8 DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • GE Healthcare
  • Fisher & Paykel Healthcare Ltd
  • Koninklijke Philips NV
  • Smiths Medical
  • Dragerwerk AG
  • Teleflex Incorporated
  • 3M Company
  • DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare)
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll